Skip to main content
. 2018 May 31;2018(5):CD011680. doi: 10.1002/14651858.CD011680.pub2

Comparison 1. Moxifloxacin versus amoxicillin‐clavulanate.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality within 30 days 1 54 Risk Ratio (M‐H, Random, 95% CI) 3.0 [0.39, 23.07]
2 Proportion of patients who experienced serious adverse events 1 54 Risk Ratio (M‐H, Random, 95% CI) 0.63 [0.30, 1.31]